Krsnaa Diagnostics Limited — Investor Meet, 19-08-2026: Analysts/Institutional Investor Meet/Con. Call Updates

Krsnaa Diagnostics reported Q1 FY27 revenue of ₹235.5 Cr (up 22% YoY), with EBITDA at ₹58.8 Cr (25% margin) and PAT at ₹16.6 Cr (7% margin). Retail revenue surged 64% YoY to ₹19.3 Cr, now 9% of total, and is targeted to reach 10-15% by FY-end, aiming for EBITDA positive by Q2.

Operational highlights include Rajasthan's substantial ramp-up (₹26 Cr revenue in Q1, aiming for ₹100-150 Cr this fiscal), 8 new MRI centers in Maharashtra, and the new Himachal Pradesh CT project. Margins saw Q1 compression due to upfront project costs but are expected to recover to double-digits by year-end as utilization improves. Management remains focused on execution, scale, and profitability, introducing innovative offerings like preventive diagnostics with financial protection. Receivable recovery efforts are ongoing for Himachal Pradesh and Karnataka. The outlook is confident on leveraging infrastructure for sustainable growth.